Loading provider…
Loading provider…
Allergy & Immunology Physician in Colorado Springs, CO
NPI: 1023125655Primary Practice Location
Audubon Surgery Center
3030 N Circle Dr, Colorado Springs, CO
Primary Employer
Colorado ENT & Allergy
coloradoent.com
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
CO State Medical License
2003 - 2027
KS State Medical License
2023 - 2025
GA State Medical License
2002 - 2005

American Board of Allergy and Immunology
Allergy & Immunology

American Board of Pediatrics
Pediatrics
Indiana University School Of Medicine
medicine.iu.edu
Residency • Pediatrics
1999 - 2002
Medical College of Georgia
augusta.edu
Fellowship • Allergy and Immunology
2002 - 2004
UVA School of Medicine
med.virginia.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 92 | 92 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 90 | 99 |
| 3 | 95004Injection of allergenic extracts into skin, accessed through the skin | 76 | 3,472 |
| 4 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 76 | 80 |
| 5 | 95165Preparation and provision of single or multiple antigens for allergen immunotherapy | 65 | 4,342 |
Fire ants represent an important risk for anaphylaxis among residents of an endemic region
Authors: Dennis Ownby
Journal: J Allergy Clin Immunol
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Placebo, DRUG: Standard of care (SoC), DEVICE: Pre-filled Syringes (PFS), BIOLOGICAL: GSK3511294 (Depemokimab), BIOLOGICAL: Mepolizumab, BIOLOGICAL: Benralizumab